Clinicopathological significance of the expression of estrogen receptor-beta and vascular endothelial growth factor-A in colorectal cancer

American Surgeon

Volumn 78, Issue 12, 2012, Pages 1376-1382

  Taggarshe, Deepa ^a   Lobocki, Catherine ^a   Silberberg, Boris ^a   Mckendrick, Alasdair ^a   Mittal, Vijay K ^a  

^a PROVIDENCE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR; TUMOR MARKER; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREVALENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; COLECTOMY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84871050426     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. Sargent DJ, Wieand HS, Haller DG, et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2005;23:8664-70. (Pubitemid 46211509)
4. Gill S, Loprinzi CL, Sargent DJ, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 2004;22:1797-806. (Pubitemid 41095169)
5. Sargent DJ, Sobrero A, Grothey A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2009;27:872-7.
6. Wingo PA, Ries LAG, Rosenberg HM, et al. Cancer incidence and mortality, 1973-1995: a report card for the US. Cancer 1998;82:1197-207. (Pubitemid 28136536)
7. Paganini-Hill A. Estrogen replacement therapy and colorectal cancer risk in elderly women. Dis Colon Rectum 1999;42:1300-5. (Pubitemid 29489363)
8. Nanda K, Bastian LA, Hasselblad V, Simel DL. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 1999;93:880-8. (Pubitemid 29197937)
9. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999;106:574-82. (Pubitemid 29231110)
10. Hebert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 1998;7:653-9. (Pubitemid 28374594)
11. Franceschi S, La Vecchia C. Colorectal cancer and hormone replacement therapy: an unexpected finding. Eur J Cancer Prev 1998;7:427-38. (Pubitemid 29030718)
12. Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-30. (Pubitemid 26190778)
13. Wada-Hiraike O, Hiraike H, Okinaga H, et al. Role of estrogen receptor beta in uterine stroma and epithelium: insights from estrogen receptor beta-/- mice. Proc Natl Acad Sci USA 2006;103:18350-5. (Pubitemid 44872762)
14. Hartman J, Lindberg K, Morani A, et al. Estrogen receptor β inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 2006;66:11207-13. (Pubitemid 46009948)
15. Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ER beta isoforms in colon cancer. Cancer Res 2001;61:632-40. (Pubitemid 32128626)
16. Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 2008;9:385-91. (Pubitemid 351411655)
17. Izbicki JR, Schmitz R, Kamran D, Izbicki W. Androgens as promoters of colon carcinogenesis. Cancer Detect Prev 1983;6:355-62.
18. Kaklamanos JG, Bathe OF, Franceschi D, et al. Expression of receptors for estrogen and progesterone in malignant colonic mucosa as a prognostic factor for patient survival. J Surg Oncol 1999;72:225-9. (Pubitemid 30007792)
19. Slattery ML, Samowitz WS, Holden JA. Estrogen and progesterone receptors in colon tumors. Am J Clin Pathol 2000;113:364-8. (Pubitemid 30217383)
20. Stedman KE, Moore GE, Morgan RT. Estrogen receptor proteins in diverse human tumors. Arch Surg 1980;115:244-8. (Pubitemid 10184025)
21. Alford TC, Do HM, Geelhoed GW, et al. Steroid hormone receptors in human colon cancers. Cancer 1979;43:980-4. (Pubitemid 9163629)
22. Foley EF, Jazaeri AA, Shupnik MA, et al. Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 2000;60:245-8. (Pubitemid 30070743)
23. Di Leo A, Barone M, Malorano E, et al. ER-beta expression in large bowel adenomas: implications in colon carcinogenesis. Dig Liver Dis 2008;40:260-6.
24. Wada-Hiraike O, Imamov O, Hiraike H, et al. Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci USA 2006;103:2959-64.
25. Giroux V, Lemay F, Bernatchez G, et al. Estrogen receptor beta deficiency enhances small intestinal tumorigenesis in APCMin/+ mice. Int J Cancer 2008;123:303-11. (Pubitemid 351842014)
26. Cho NL, Javid SH, Carothers AM, et al. Estrogen receptors alpha and beta are inhibitory modifiers of Apc dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res 2007;67:2366-72. (Pubitemid 46437055)
27. Qiu Y, Waters CE, Lewis AE, et al. Oestrogen induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 2002;174:369-77.
28. Hsu HH, Cheng SF, Wu CC, et al. Apoptotic effects of overexpressed estrogen receptor beta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner. Chin J Physiol 2006;49:110-6.
29. Hanrahan V, Currie MJ, Gunningham SP, et al. The angiogenic switch for vascular endothelial growth factor(VEGF)-A, VEGF-B, VEGF-C and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol 2003;200:183-94. (Pubitemid 36748027)
30. Kang SM, Maeda K, Onoda N, et al. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int J Cancer 1997;74:502-7. (Pubitemid 27486506)
31. Barone M, Tanzi S, Lofano K, et al. Estrogens, phytoestrogens and colorectal neoproliferative lesions. Genes Nutr 2008;3:7-13.